Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep

Vaccine

Volumn 27, Issue 52, 2009, Pages 7326-7330

  Oura, C A L ^a   Wood, J L N ^b   Sanders, A J ^a   Bin Tarif, A ^a   Henstock, M ^a   Edwards, L ^a   Floyd, T ^b   Simmons, H ^c   Batten, C A ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Bluetongue serotype 8; ELISA; Inactivated vaccine; Sheep

Indexed keywords

BOVILIS; INACTIVATED VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLUETONGUE ORBIVIRUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPEAN UNION; MASS IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEROCONVERSION; SEROTYPE; SHEEP; SHEEP DISEASE; SINGLE DRUG DOSE; UNITED KINGDOM; VIRUS ISOLATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; NEUTRALIZATION TESTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SHEEP; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 70849116852     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.070     Document Type: Article

References (17)

1. Saegerman C., Berkvens D., and Mellor P.S. Bluetongue epidemiology in the European Union. Emerging Infectious Diseases 14 4 (2008) 539-544
2. Hoffmann B., Sasserath M., Thalheim S., Bunzenthal C., Strebelow G., and Beer M. Bluetongue virus serotype 8 reemergence in Germany, 2007 and 2008. Emerging Infectious Diseases 14 9 (2008) 1421-1423
3. Gloster J., Burgin L., Witham C., Athanassiadou M., and Mellor P.S. Bluetongue in the United Kingdom and northern Europe in 2007 and key issues for 2008. Veterinary Record 162 10 (2008) 298-302
4. Gloster J., Mellor P.S., Burgin L., Ganders C., and Carpenter S. Will Bluetongue come on the wind to the United Kingdom in 2007?. Veterinary Record 160 (2007) 422-426
5. Savini G., MacLaclalan N.J., Sanchez-Vinaino J.M., and Zientara S. Vaccines against bluetongue in Europe. Comparative Immunology Microbiology and Infectious Diseases 31 2-3 (2008) 101-120
6. Burgin L., Gloster J., and Mellor P.S. Why were there no outbreaks of Bluetongue in the UK during 2008?. Veterinary Record 164 13 (2009) 384-387
7. Batten C.A., Sanders A.J., Bachanek-Bankowska K., Bin-Tarif A., and Oura C.A.L. Bluetongue virus: European Community proficiency test (2007) to evaluate ELISA and RT-PCR detection methods with special reference to pooling of samples. Veterinary Microbiology 135 3-4 (2009) 380-383
8. Batten C.A., Bachanek-Bankowska K., Bin-Tarif A., Kgosana L., Swain A.J., Corteyn M., et al. Bluetongue virus: European Community inter-laboratory comparison tests to evaluate ELISA and RT-PCR detection methods. Veterinary Microbiology 129 1-2 (2008) 80-88
9. Shaw A., Monaghan P., Alpar H.O., Anthony S., Darpel K.E., Batten C.A., et al. Development and validation of a real-time RT-PCR assay to detect genome bluetongue virus segment 1. Journal of Virological Methods 145 2 (2007) 115-126
10. Haig D.A., McKercher D.G., and Alexander R.A. The cytopathic action of bluetongue virus in tissue culture and its application to the detection of antibodies in the serum of sheep. Onderstepoort Journal of Veterinary Research 27 (1956) 171-177
11. Office International des Epizooties (OIE). Bluetongue. In: Manual of diagnostic tests and vaccines for terrestrial animals. Paris, OIE, 2008. Available from: http://www.oie.int/eng/normes/mmanual/2008/pdf/2.01.03_BLUETONGUE.pdf.
12. Savini G., Ronchi G.F., Leone A., Ciarelli A., Mighaccio P., Franchi P., et al. An inactivated vaccine for the control of Bluetongue virus serotype 16 infection in sheep in Italy. Veterinary Microbiology 124 1-2 (2007) 140-146
13. Savini G., Hamers C., Conte A., Migliaccio P., Bonfini B., Teodori L., et al. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Veterinary Microbiology 133 1-2 (2009) 1-8
14. Hamers C., Rehbein S., Hudelet P., Blanchet M., Lapostolle B., Cariou C., et al. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep. Vaccine 27 21 (2009) 2789-2793
15. Eschbaumer M., Hoffmann B., König P., Teifke J.P., Gethmann J.M., Conraths F.J., et al. Efficacy of three inactivated vaccines against Bluetongue virus serotype 8 in sheep. Vaccine 27 31 (2009) 4169-4175
16. Huismans H., and Erasmus B.J. Identification of serotype-specific and group-specific antigens of Bluetongue virus. Onderstepoort Journal of Veterinary Research 48 2 (1981) 51-58
17. Savini G., Monaco F., Citarella R., Calzetta G., Panichi G., Ruiu A., et al. Monovalent modified-live vaccine against Bluetongue virus serotype 2: immunity studies in cows. Veterinaria Italiana 40 4 (2004) 664-667